More Articles

The U.S. House passed legislation yesterday that would give the Food and Drug Administration
more authority to regulate companies that compound sterile drugs and ship them across state lines.

The bill, called the Drug Quality and Security Act, now goes to the Senate for a vote. House
and Senate committees agreed on the legislation on Wednesday.

Introduced after a deadly outbreak of fungal meningitis killed more than 50 people last year,
the act also would create a set of standards to track pharmaceuticals through the distribution
chain to thwart the introduction of fake medication into the drug supply.